Clinical trial
Mechanisms and Treatment of Intradialytic Hypertension - Sodium
NCT01371890 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms and Treatment of Intradialytic Hypertension - Sodium
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, hemodialysis, hypertension, intradialytic hypertension